230 related articles for article (PubMed ID: 27031829)
21. Hepatitis C Virus Proteins Core and NS5A Are Highly Sensitive to Oxidative Stress-Induced Degradation after eIF2α/ATF4 Pathway Activation.
Ríos-Ocampo WA; Navas MC; Buist-Homan M; Faber KN; Daemen T; Moshage H
Viruses; 2020 Apr; 12(4):. PubMed ID: 32283772
[TBL] [Abstract][Full Text] [Related]
22. Identification of ionotrophic purinergic receptors in Huh-7 cells and their response towards structural proteins of HCV genotype 3a.
Manzoor S; Idrees M; Ashraf J; Mehmood A; Butt S; Fatima K; Akbar H; Rehaman IU; Qadri I
Virol J; 2011 Sep; 8():431. PubMed ID: 21899776
[TBL] [Abstract][Full Text] [Related]
23. HCV-induced EGFR-ERK signaling promotes a pro-inflammatory and pro-angiogenic signature contributing to liver cancer pathogenesis.
Benkheil M; Paeshuyse J; Neyts J; Van Haele M; Roskams T; Liekens S
Biochem Pharmacol; 2018 Sep; 155():305-315. PubMed ID: 30012461
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C Virus NS5A Protein Promotes the Lysosomal Degradation of Hepatocyte Nuclear Factor 1α via Chaperone-Mediated Autophagy.
Matsui C; Deng L; Minami N; Abe T; Koike K; Shoji I
J Virol; 2018 Jul; 92(13):. PubMed ID: 29695419
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
[TBL] [Abstract][Full Text] [Related]
26. Evolution of hepatitis C virus non-structural 5A gene in the progression of liver disease to hepatocellular carcinoma.
De Mitri MS; Cassini R; Bagaglio S; Morsica G; Andreone P; Marino N; Bernardi M
Liver Int; 2007 Oct; 27(8):1126-33. PubMed ID: 17845542
[TBL] [Abstract][Full Text] [Related]
27. Golgi protein 73 facilitates the interaction of hepatitis C virus NS5A with apolipoprotein E to promote viral particle secretion.
Zhang X; Wang T; Dai X; Zhang Y; Jiang H; Zhang Q; Liu F; Wu K; Liu Y; Zhou H; Wu J
Biochem Biophys Res Commun; 2016 Oct; 479(4):683-689. PubMed ID: 27697522
[TBL] [Abstract][Full Text] [Related]
28. Focal adhesion kinase (FAK) mediates the induction of pro-oncogenic and fibrogenic phenotypes in hepatitis C virus (HCV)-infected cells.
Alisi A; Arciello M; Petrini S; Conti B; Missale G; Balsano C
PLoS One; 2012; 7(8):e44147. PubMed ID: 22937161
[TBL] [Abstract][Full Text] [Related]
29. Intracellular Accumulation of IFN-λ4 Induces ER Stress and Results in Anti-Cirrhotic but Pro-HCV Effects.
Onabajo OO; Wang F; Lee MH; Florez-Vargas O; Obajemu A; Tanikawa C; Vargas JM; Liao SF; Song C; Huang YH; Shen CY; Banday AR; O'Brien TR; Hu Z; Matsuda K; Prokunina-Olsson L
Front Immunol; 2021; 12():692263. PubMed ID: 34497603
[No Abstract] [Full Text] [Related]
30. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.
Benvegnù L; Fattovich G; Noventa F; Tremolada F; Chemello L; Cecchetto A; Alberti A
Cancer; 1994 Nov; 74(9):2442-8. PubMed ID: 7922998
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C Virus Downregulates Core Subunits of Oxidative Phosphorylation, Reminiscent of the Warburg Effect in Cancer Cells.
Gerresheim GK; Roeb E; Michel AM; Niepmann M
Cells; 2019 Nov; 8(11):. PubMed ID: 31717433
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular carcinoma and infections with multiple hepatitis viruses.
Brunetto MR; Oliveri F; Colombatto P; Bonino F
Princess Takamatsu Symp; 1995; 25():61-6. PubMed ID: 8875610
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma.
Chung YL; Sheu ML; Yen SH
Int J Cancer; 2003 Oct; 107(1):65-73. PubMed ID: 12925958
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of proproliferative genes and the ligand/receptor pair placental growth factor and vascular endothelial growth factor receptor 1 in hepatitis C cirrhosis.
Huang XX; McCaughan GW; Shackel NA; Gorrell MD
Liver Int; 2007 Sep; 27(7):960-8. PubMed ID: 17696935
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus NS5A protein blocks epidermal growth factor receptor degradation via a proline motif- dependent interaction.
Igloi Z; Kazlauskas A; Saksela K; Macdonald A; Mankouri J; Harris M
J Gen Virol; 2015 Aug; 96(8):2133-2144. PubMed ID: 25872741
[TBL] [Abstract][Full Text] [Related]
37. Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma.
El-Bassiouny AE; Zoheiry MM; Nosseir MM; El-Ahwany EG; Ibrahim RA; El-Bassiouni NE
MedGenMed; 2007 Aug; 9(3):45. PubMed ID: 18092051
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis.
Anzola M
J Viral Hepat; 2004 Sep; 11(5):383-93. PubMed ID: 15357643
[TBL] [Abstract][Full Text] [Related]
39. Nonstructural 5A protein activates beta-catenin signaling cascades: implication of hepatitis C virus-induced liver pathogenesis.
Park CY; Choi SH; Kang SM; Kang JI; Ahn BY; Kim H; Jung G; Choi KY; Hwang SB
J Hepatol; 2009 Nov; 51(5):853-64. PubMed ID: 19726098
[TBL] [Abstract][Full Text] [Related]
40. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
